Oncocross Co.,Ltd.
An AI biotechnology firm that develops drugs by predicting drug-disease interactions.
382150 | KO
Overview
Corporate Details
- ISIN(s):
- KR7382150001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 법원로11길 7 905호(문정동, 문정현대지식산업센터1-2), 서울특별시
- Website:
- https://www.oncocross.com/en
Description
Oncocross is an artificial intelligence (AI) biotechnology company specializing in drug development. The company utilizes proprietary AI platforms, including RAPTOR AI™, which analyze a comprehensive, medically curated transcriptome database of patients, drugs, and diseases. This technology is used to predict interactions between drugs and diseases, enabling the identification of optimal indications for new and existing compounds. Oncocross focuses on developing treatments for cancer, rare diseases, and other intractable conditions. Its approach aims to accelerate the drug development process, reduce costs, and increase the success rate of clinical trials by identifying promising drug candidates and expanding their potential applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-19 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 58.2 KB | ||
| 2024-12-18 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 60.0 KB | ||
| 2024-12-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2024-12-12 00:00 |
증권발행실적보고서
|
Korean | 159.3 KB | ||
| 2024-12-05 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 440.6 KB | ||
| 2024-12-05 00:00 |
[기재정정]투자설명서
|
Korean | 3.6 MB | ||
| 2024-12-02 00:00 |
투자설명서
|
Korean | 3.1 MB | ||
| 2024-11-28 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.4 MB | ||
| 2024-11-08 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 21.0 KB | ||
| 2024-11-08 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 5.1 MB | ||
| 2024-11-07 00:00 |
분기보고서 (2024.09)
|
Korean | 1.1 MB | ||
| 2024-10-16 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 15.0 KB | ||
| 2024-10-16 00:00 |
[첨부추가]증권신고서(지분증권)
|
Korean | 2.9 MB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 998.9 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.0 MB |
Automate Your Workflow. Get a real-time feed of all Oncocross Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oncocross Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oncocross Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
